DJIA 18,034.93 208.63 1.17%
NASDAQ 4,994.60 62.79 1.27%
S&P 500 2,100.40 19.22 0.92%
market minute promo

Celgene (NASDAQ: CELG)

114.75 1.28 (1.13%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $114.75 1.13%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $114.40
Previous Close $113.47
Daily Range $113.03 - $114.77
52-Week Range $68.38 - $129.06
Market Cap $91.9B
P/E Ratio 47.48
Dividend (Yield) $0.00 (0.0%)
Volume 4,486,301
Average Daily Volume 5,811,604
Current FY EPS $4.42

Sector

Healthcare

Industry

Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary

How to Invest Money in Biotech

If you want to invest money in biotech, you first need to understand what catalysts tend to determine biotech stock valuations, and what your three best pathways are to becoming a successful biotech investor.

Jim Cramer's 'Mad Money' Recap: How to Become an Even Better Investor

These Companies Probably Won't Be Acquiring Ariad Pharmaceuticals

Celgene: A Pre-Earnings Discussion Based On Recent News

4 Big Biopharma Deals We Might See In 2015

Phase II Data for Apremilast in Beh├žet's Disease Published in The New England Journal of Medicine

Why Goldman Sachs Is Wrong About These 3 Stocks - Analyst Blog

The Best Long And Short Ideas From The 2015 UGA SMIF Stock Pitch Challenge Sponsored By Seeking Alph

The Best Long And Short Ideas From The 2015 UGA SMIF Stock Pitch Challenge Sponsored By Seeking Alpha

Trillium Therapeutics Is An Overvalued Biotech Stock

7 Trends Drug Investors Should Know

See More CELG News...

CELG's Top Competitors

CELG $114.75 (1.13%)
Current stock: CELG
AMGN $165.97 (1.46%)
Current stock: AMGN
GILD $100.66 (-0.72%)
Current stock: GILD
$0.00 (0.00%)
Current stock: